Cronos Group Inc.
General ticker "CRON" information:
- Sector: Health Care
- Industry: Drug Manufacturers - Specialty & Generic
- Capitalization: $814.2M (TTM average)
Cronos Group Inc. follows the US Stock Market performance with the rate: 55.8%.
Estimated limits based on current volatility of 3.2%: low 2.56$, high 2.72$
Factors to consider:
- Total employees count: 459 (+28.9%) as of 2024
- Top business risk factors: Market competition, Regulatory and compliance, Supply chain disruptions, Intellectual property risks, Reputation and brand risks
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [1.26$, 2.62$]
- 2025-12-31 to 2026-12-31 estimated range: [1.24$, 2.58$]
Financial Metrics affecting the CRON estimates:
- Positive: with PPE of -32.7 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Positive: Investing cash flow per share per price, % of 23.34 > -0.63
- Positive: Industry inventory ratio change (median), % of -1.58 <= -0.18
- Positive: Inventory ratio change, % of -3.91 <= -0.75
- Positive: 1.84 < Return on assets ratio (scaled to [-100,100]) of 3.32
- Positive: Shareholder equity ratio, % of 91.23 > 64.37
- Positive: Interest expense per share per price, % of 0 <= 0.01
Short-term CRON quotes
Long-term CRON plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $86.75MM | $87.24MM | $117.61MM |
| Operating Expenses | $198.18MM | $172.04MM | $194.14MM |
| Operating Income | $-111.43MM | $-84.80MM | $-76.53MM |
| Non-Operating Income | $-9.57MM | $11.13MM | $113.11MM |
| Interest Expense | $0.01MM | $0.00MM | $0.00MM |
| R&D Expense | $13.13MM | $5.84MM | $4.23MM |
| Income(Loss) | $-121.00MM | $-73.67MM | $36.59MM |
| Taxes | $34.17MM | $-3.23MM | $-3.44MM |
| Profit(Loss)* | $-168.73MM | $-73.96MM | $41.08MM |
| Stockholders Equity | $1,143.88MM | $1,099.57MM | $1,064.06MM |
| Inventory | $37.56MM | $30.50MM | $33.15MM |
| Assets | $1,213.01MM | $1,140.27MM | $1,166.31MM |
| Operating Cash Flow | $-88.95MM | $-42.84MM | $18.84MM |
| Capital expenditure | $5.03MM | $3.42MM | $13.15MM |
| Investing Cash Flow | $-1.84MM | $-59.50MM | $175.15MM |
| Financing Cash Flow | $-2.90MM | $-1.03MM | $-1.23MM |
| Earnings Per Share** | $-0.45 | $-0.18 | $0.11 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.